Related Experiment Video
Updated: Jun 23, 2026
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Remission in schizophrenia: analysis in a naturalistic setting
Jonas Eberhard1, Sten Levander, Eva Lindström
1Department of Clinical Science, Lund University, Lund SE-22185, Sweden. jonas.eberhard@med.lu.se
Comprehensive Psychiatry
|April 21, 2009
Summary
Schizophrenia remission criteria primarily measure symptoms, not cognition or medication, and may overemphasize symptom control over broader recovery. This study evaluated these criteria in a real-world setting.
Area of Science:
- Psychiatry
- Clinical Psychology
- Neuroscience
Background:
- Schizophrenia remission criteria are newly defined.
- Naturalistic settings are crucial for evaluating clinical applicability.
- Longitudinal data is needed to assess remission stability and impact.
Purpose of the Study:
- Investigate the Positive and Negative Syndrome Scale for Schizophrenia (PANSS) remission criteria in a naturalistic setting.
- Identify factors influencing remission status changes.
- Validate criteria against global illness indices, cognition, and social outcomes.
Main Methods:
- Longitudinal naturalistic study of 162 schizophrenia patients over 5 years.
- Patients treated with risperidone, with annual assessments of symptoms, cognition, and social outcome.
- Remission status determined retrospectively based on symptom stability.
Main Results:
- Symptomatic remission observed in 40% at baseline, rising to 55-60%.
- Hospitalization rates decreased significantly over time.
- Remission associated with global illness indices and social outcomes, but not cognition or medication.
Conclusions:
- Current remission criteria are primarily symptomatic and may not capture full recovery.
- Clinical relevance exists, but overemphasis on symptom control is a risk.
- Further research needed to refine remission definitions for comprehensive schizophrenia care.
Related Concept Videos
01:29Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:30Negative and Cognitive Symptoms of Schizophrenia
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...